Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - naltrexone hydrochloride, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; iron oxide red; macrogol 400 - naltrexone astron is indicated for use within a comprehensive treatment program for alcohol dependence. naltrexone astron is also indicated as adjunctive therapy in the maintenance of formerly opioid-dependent patients who have ceased the use of opioids such as diamorphine (heroin) and morphine.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - naltrexone hydrochloride, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; iron oxide red; macrogol 400 - naltrexone intas is indicated for use within a comprehensive treatment program for alcohol dependence. naltrexone intas is also indicated as adjunctive therapy in the maintenance of formerly opioid-dependent patients who have ceased the use of opioids such as diamorphine (heroin) and morphine.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

zambon s.p.a. - naltrexone (naltrexone hydrochloride) - capsules - 50mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

inova pharmaceuticals (singapore) pte ltd (incorporated in singapore) malaysia branch - bupropion; naltrexone -

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c), naltrexone hydrochloride (unii: z6375yw9sf) (naltrexone - unii:5s6w795cqm) - morphine sulfate 20 mg - embeda is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see warnings and precautions (5.1)] , reserve embeda for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - embeda is not indicated as an as-needed (prn) analgesic. embeda is contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.3)] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings and precautions (5.6)] - con

United States - English - NLM (National Library of Medicine)

advanced pharmaceutical technology, inc. - naltrexone (unii: 5s6w795cqm) (naltrexone - unii:5s6w795cqm) - if pouch is damaged or open since it will no longer be sterile.

Australia - English - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - naltrexone hydrochloride -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - naltrexone hydrochloride - oral suspension - 2.5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - naltrexone hydrochloride - oral suspension - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

part viiid drug tariff special order - naltrexone hydrochloride - oral capsule - 4.5mg